Over recent years, mesenchymal stem/stromal cells (MSCs) and their potential biomedical
applications have received much attention from the global scientific community in an …

Abstract Interleukin (IL)‐1 receptor antagonist (IL‐1Ra), a naturally occurring antagonist of IL‐
1α/IL‐1β signaling pathways, has been attributed to the immunosuppressive effects of …

The COVID-19 pandemic has negatively impacted the global public health and the
international economy; therefore, there is an urgent need for an effective therapy to treat …

Osteoarthritis (OA) is a low-grade inflammatory disorder of the joints that causes
deterioration of the cartilage, bone remodeling, formation of osteophytes, meniscal damage …

Autoimmune diseases, chronic in nature, are generally hard to alleviate. Present long‐term
treatments with available drugs such as steroids, immune‐suppressive drugs, or antibodies …

Mesenchymal stem cells (MSCs) exhibit potent immunoregulatory abilities by interacting
with cells of the adaptive and innate immune system. In vitro, MSCs inhibit the differentiation …

Rheumatoid arthritis (RA) is a disease of the joints that causes decreased quality of life.
Mesenchymal stromal cells (MSCs) have immunosuppressive properties, with possible use …

Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated
with several complications. Adipose tissue-derived mesenchymal stem cells (AT-MSCs) …

ABSTRACT Introduction: Mesenchymal stromal cells (MSCs) present unique
immunomodulatory properties that make them promising candidates for the treatment of …

Systemic sclerosis associated with lung interstitial lung disease (SSc-ILD) is the most
common cause of death among patients with SSc. Mesenchymal stem cell (MSCs) …